Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy
Open accessPublished version of a preprint
Abstract
Background: Acute mesenteric ischemia (AMI) is a dreaded condition with a difficult diagnosis and high mortality. Due to different baseline situations, the frequently performed comparison between endovascular and open surgical treatment is interfered with selection bias. The purpose of this study was to review outcomes in AMI treatment with an open or endovascular approach in association with laparotomy and to evaluate the endovascular-first strategy in similar clinical situations. Methods: The clinical data of 74 patients treated for AMI from 2007 to 2021 were retrospectively reviewed and compared. In-hospital mortality was appointed as the primary study endpoint. Risk factors for mortality were identified by using univariate and multivariate analysis. Results: In total, 61 patients (82%) were treated open surgically (OT) and, 13 patients (18%) with an endovascular approach (ET) in combination with laparatomy. The etiology of AMI was 49% arteriosclerotic and 51% thromboembolic occlusions. The total in-hospital mortality manifested at 43% ( n =32) (OT 41% vs. ET 53.8%; P =0.54). As independent risk factors for in-hospital mortality, pneumatosis intestinalis ( P =0.01), increased lactate concentration ( P =0.04), and ischemic intestinal sections ( P =0.01) were identified. Additionally, on univariate analysis patient age, congestive heart failure (> NYHA II) and atrial fibrillation were related with higher mortality. Conclusions: Morbidity and mortality of AMI remains at a high level. Conventional open or intraoperative endovascular therapy achieved similar results in patients with indication for laparotomy. Advanced disease stage with ischemic intestinal sections at presentation and cardiovascular comorbidities were associated with adverse outcome.
AI snapshot
Written from the paper’s full text.
TL;DR
In this retrospective single-center study of 74 patients with acute mesenteric ischemia requiring laparotomy, in-hospital mortality was 43.3% and did not differ significantly between open (41%) and intraoperative endovascular (53.8%) revascularization. Pneumatosis intestinalis, increased lactate, and remaining ischemic intestinal sections independently predicted mortality.
Key findings
- Overall in-hospital mortality was 43.3% (n = 32); open treatment 41% (n = 25) vs. endovascular treatment 53.8% (n = 7), P = 0.54.
- Independent risk factors for in-hospital mortality were pneumatosis intestinalis (OR 1.4; 95% CI 1.1–6.7; P = 0.01), increased lactate concentration (OR 1.5; 95% CI 1.1–13; P = 0.04), and ischemic intestinal sections (OR 3.5; 95% CI 1.3–13.9; P = 0.01).
- Etiology was arteriosclerotic in 49% and thromboembolic in 51%; all endovascular-treated occlusions were arteriosclerotic (100%, P < 0.001), and endovascular-treated occlusions were shorter (2.07 ± 0.63 cm vs. 3.89 ± 1.98 cm; P = 0.01).
- Endovascular technical failure occurred in 38.5% (5/13), all converted to immediate open revascularization; failure had no significant influence on survival (66.7% vs. 33.3%; P = 0.59). Kaplan-Meier 1-year and 5-year survival were 85.5% and 58.8%.
Methods
- Retrospective review of patients treated for acute mesenteric ischemia between 01/2007 and 01/2021 at the Carl Gustav Carus University Hospital, Dresden; 74 patients analyzed, identified by ICD code K55.0. Inclusion required clinical symptoms and CTA evidence of thromboembolic or arteriosclerotic occlusion of at least one mesenteric main stem vessel; endovascular patients were included only if treated intraoperatively with laparotomy.
- Primary endpoint was in-hospital mortality; secondary outcomes included technical success, morbidity, long-term survival, and revision rates.
- Statistical analysis used univariate tests, binary logistic regression for perioperative mortality, and Kaplan-Meier estimates with log-rank tests; two-sided P < 0.05 was significant.
Limitations
- The paper states it is a retrospective single-center study with bias linked to retrospective data collection; the long study period included progress in medical therapy and endovascular technology that may have affected outcomes; the small number of endovascular-treated patients and limited follow-up precluded a comprehensive comparison, and selection bias cannot be avoided.
- The text also makes evident an internal inconsistency: one Results sentence reports 76 patients, while the abstract, tables, and analysis use 74 patients.
- The endovascular group was small (n = 13) and included only arteriosclerotic occlusions, limiting comparability with the open group; time from symptom onset to treatment could not be reliably recorded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
- Findingown data
85.1% (n=63) of patients developed complications greater than grade IIIa according to the Clavien-Dindo classification.
“According to the Clavien-Dindo classification, 85.1% (n =63) patients developed complications greater than grade IIIa (Table 3) [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213 source
Not checked in the free run.
- Findingown data
The mean follow-up was 19 months (range 6.5-46 months).
“The mean follow-up was 19 months (range 6.5–46 months) and available in 30/42 patients (65.3%).”
Quote in the paperNot a substantial claim - Findingown data
Increased lactate concentration was an independent risk factor for in-hospital mortality (P=0.04).
“As independent risk factors for in-hospital mortality, pneumatosis intestinalis (P=0.01), increased lactate concentration (P=0.04), and ischemic intestinal sections (P=0.01) were identified.”
Quote in the paperSubstantial claim - Findingown data
22 patients (29.7%) who had already undergone an initial resection required additional resection from remaining ischemic intestinal sections in the postoperative course.
“Furthermore, in the postoperative course 22 patients (29.7%) which have already undergone an initial resection, required additional resection from remaining ischemic intestinal sections.”
Quote in the paperNot a substantial claim - Findingown data
For the entire cohort, intensive care unit stay was 11 days (range 5-26 days).
“For the entire cohort, hospital stay was 23 days (range 14–37 days) and intensive care unit stay was 11 days (range 5–26 days).”
Quote in the paperNot a substantial claim
- Findingown data
Ischemic intestinal sections was an independent risk factor for in-hospital mortality (P=0.01).
“As independent risk factors for in-hospital mortality, pneumatosis intestinalis (P=0.01), increased lactate concentration (P=0.04), and ischemic intestinal sections (P=0.01) were identified.”
Quote in the paperSubstantial claim - Findingown data
The occlusion length was shorter in the endovascular treatment group compared to the primary open surgical approach (2.07cm ± 0.63cm vs. 3.89cm ± 1.98cm; P = 0.01).
“The occlusion length was shorter (2.07cm ± 0.63cm vs. 3.89cm ± 1.98cm; P = 0.01), and the occlusion localization was more centrally located compared to the primary open surgical approach (0.72cm ± 0.88cm vs. 2.41cm ± 2.79cm; P = 0.09).”
Quote in the paperNot a substantial claim - Findingown data
Five endovascular interventions (38.5%) were unsuccessful because the mesenteric vessel occlusion could not be passed or entered.
“Five endovascular interventions (38.5%) were unsuccessful, as the mesenteric vessel occlusion could not be passed or entered.”
Quote in the paperNot a substantial claim - Findingown data
In the early postprocedural period, two OT patients (3.3%) required vascular revision due to complications (bleeding complication n=1 and re-thrombosis n=1).
“In the early postprocedural period two OT patients (3.3%) required vascular revision due to complications (bleeding complication n = 1 and re-thrombosis n = 1).”
Quote in the paperNot a substantial claim - Findingown data
Total in-hospital mortality was 43% (n=32).
“The total in-hospital mortality manifested at 43% (n =32) (OT 41% vs. ET 53.8%; P=0.54).”
Quote in the paperSubstantial claim - Findingown data
A total of four patients (5.4%) needed vascular reoperations or reinterventions.
“A total of four patients (5.4%) needed vascular reoperations or reinterventions.”
Quote in the paperNot a substantial claim - Findingown data
For the entire cohort, hospital stay was 23 days (range 14-37 days).
“For the entire cohort, hospital stay was 23 days (range 14–37 days) and intensive care unit stay was 11 days (range 5–26 days).”
Quote in the paperNot a substantial claim - Findingown data
The occlusion localization was more centrally located in the endovascular treatment group compared to the primary open surgical approach (0.72cm ± 0.88cm vs. 2.41cm ± 2.79cm; P = 0.09).
“The occlusion length was shorter (2.07cm ± 0.63cm vs. 3.89cm ± 1.98cm; P = 0.01), and the occlusion localization was more centrally located compared to the primary open surgical approach (0.72cm ± 0.88cm vs. 2.41cm ± 2.79cm; P = 0.09).”
Quote in the paperNot a substantial claim - Findingown data
The in-hospital mortality of all revascularized patients (n=74) was 43.3% (n=32).
“The in-hospital mortality of all revascularized patients (n =74) was 43.3% (n = 32) without a significant difference in treatment modalities (OT 41% [n =25] vs. ET 53.8% [n =7]; P =0.54) or a significant decrease during the last 10 years.”
Quote in the paperSubstantial claim - Findingown data
Patients with unsuccessful endovascular interventions received immediate open revascularization.
“These patients received immediate open revascularization.”
Quote in the paperNot a substantial claim - Findingown data
There was no significant difference in in-hospital mortality between open (OT) and endovascular (ET) treatment modalities (OT 41% [n=25] vs. ET 53.8% [n=7]; P=0.54).
“The in-hospital mortality of all revascularized patients (n =74) was 43.3% (n = 32) without a significant difference in treatment modalities (OT 41% [n =25] vs. ET 53.8% [n =7]; P =0.54) or a significant decrease during the last 10 years.”
Quote in the paperSubstantial claim - Findingown data
All thromboembolic occlusions were treated primarily by open surgery.
“All thromboembolic occlusions were treated primarily by open surgery.”
Quote in the paperNot a substantial claim - Findingown data
On univariate analysis, atrial fibrillation was related with higher mortality.
“Additionally, on univariate analysis patient age, congestive heart failure (> NYHA II) and atrial fibrillation were related with higher mortality.”
Quote in the paperNot a substantial claim - Findingown data
There were seven late deaths.
“There were seven late deaths.”
Quote in the paperNot a substantial claim - Findingown data
Follow-up was available in 30/42 patients (65.3%).
“The mean follow-up was 19 months (range 6.5–46 months) and available in 30/42 patients (65.3%).”
Quote in the paperNot a substantial claim - Findingown data
Pneumatosis intestinalis was an independent risk factor for in-hospital mortality (P=0.01).
“As independent risk factors for in-hospital mortality, pneumatosis intestinalis (P=0.01), increased lactate concentration (P=0.04), and ischemic intestinal sections (P=0.01) were identified.”
Quote in the paperSubstantial claim - Findingown data
Only arteriosclerotic occlusions were treated endovascularly (100%, P < 0.001).
“Only arteriosclerotic occlusions were treated endovascularly (100%, P < 0.001).”
Quote in the paperNot a substantial claim - Findingown data
In-hospital mortality did not significantly decrease during the last 10 years.
“The in-hospital mortality of all revascularized patients (n =74) was 43.3% (n = 32) without a significant difference in treatment modalities (OT 41% [n =25] vs. ET 53.8% [n =7]; P =0.54) or a significant decrease during the last 10 years.”
Quote in the paperNot a substantial claim - Findingown data
On univariate analysis, patient age was related with higher mortality.
“Additionally, on univariate analysis patient age, congestive heart failure (> NYHA II) and atrial fibrillation were related with higher mortality.”
Quote in the paperNot a substantial claim - Findingown data
On univariate analysis, congestive heart failure (> NYHA II) was related with higher mortality.
“Additionally, on univariate analysis patient age, congestive heart failure (> NYHA II) and atrial fibrillation were related with higher mortality.”
Quote in the paperNot a substantial claim - Findingown data
Raised lactate concentration was a multivariate predictor of in-hospital mortality (OR 1.5; 95% CI 1.1-13; P=0.04).
“In multivariate analysis, predictors of mortality were raised lactate concentration (OR 1.5; 95% CI 1.1–13; P = 0.04), pneumatosis intestinalis in CTA (OR 1.4; 95% CI 1.1–6.7; P = 0.01) and remaining ischemic intestinal sections in second-look operations (OR 3.5; 95% CI 1.3–13.9; P = 0.01) (Table 5).”
Quote in the paperSubstantial claim - Findingown data
Remaining ischemic intestinal sections in second-look operations was a multivariate predictor of in-hospital mortality (OR 3.5; 95% CI 1.3-13.9; P=0.01).
“In multivariate analysis, predictors of mortality were raised lactate concentration (OR 1.5; 95% CI 1.1–13; P = 0.04), pneumatosis intestinalis in CTA (OR 1.4; 95% CI 1.1–6.7; P = 0.01) and remaining ischemic intestinal sections in second-look operations (OR 3.5; 95% CI 1.3–13.9; P = 0.01) (Table 5).”
Quote in the paperSubstantial claim - Findingown data
Pneumatosis intestinalis in CTA was a multivariate predictor of in-hospital mortality (OR 1.4; 95% CI 1.1-6.7; P=0.01).
“In multivariate analysis, predictors of mortality were raised lactate concentration (OR 1.5; 95% CI 1.1–13; P = 0.04), pneumatosis intestinalis in CTA (OR 1.4; 95% CI 1.1–6.7; P = 0.01) and remaining ischemic intestinal sections in second-look operations (OR 3.5; 95% CI 1.3–13.9; P = 0.01) (Table 5).”
Quote in the paperSubstantial claim - Findingreasoning
Arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P=0.11).
“Moreover, arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P = 0.11), probably due to a larger and more poorly compensated bowel ischemia [1, 11].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Berland T, Oldenburg WA (2008) Acute mesenteric ischemia. Curr Gastroenterol Rep 10(3):341–346 source
Not checked in the free run.
- cites [11] Arthurs ZM et al (2011) A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53(3):698–705 source
Not checked in the free run.
- Findingown data
In 38.5% of the patients the endovascular approach was technically unsuccessful due to the impossibility of probing the target vessel.
“Furthermore, it must be mentioned that in 38.5% of the patients the endovascular approach was technically unsuccessful due to the impossibility of probing the target vessel.”
Quote in the paperNot a substantial claim - Findingown data
Initial endovascular failure had no significant influence on survival (66.7% vs. 33.3%; P=0.59).
“Initial endovascular failure had no significant influence on survival (66.7% vs. 33.3%; P = 0.59).”
Quote in the paperNot a substantial claim - Findingown data
Endovascular failure did not increase mortality rates (P=0.59).
“However, endovascular failure did not increase mortality rates (P = 0.59).”
Quote in the paperSubstantial claim - Findingown data
Patients with an initial wrong clinical diagnosis tended to survive worse (37.5% [n=12] vs. 62.5% [n=20]; P=0.07).
“Patients with an initial wrong clinical diagnosis tended to survive worse 37.5% (n =12) vs. 62.5% (n =20) (P = 0.07).”
Quote in the paperNot a substantial claim - Findingown data
Primary referral diagnosis of AMI was placed correctly in only 62% of the patients.
“Primary referral diagnosis of AMI was placed correctly in only 62% of the patients.”
Quote in the paperNot a substantial claim - Findingown data
Patients with a wrong referral diagnosis had worse survival than patients with a correct referral diagnosis (38% vs. 63%; P=0.07).
“Even so, patients with a wrong referral diagnosis had worse survival than patients with a correct referral diagnosis (38% vs. 63%; P= 0.07).”
Quote in the paperNot a substantial claim - Findingown data
In our study, patients with thrombotic occlusions had significantly higher rates of POAD (76%; P<0.01).
“Moreover, in our study patients with thrombotic occlusions had significantly higher rates of POAD (76%; P < 0.01).”
Quote in the paperNot a substantial claim - Findingcitation
The SMA was occluded in all patients.
“In accordance with the literature, the SMA was occluded in all patients [15, 17].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15] Eckstein HH (2003) Acute mesenteric ischemia. Resection or reconstruction? Chirurg 74(5):419–431 source
Not checked in the free run.
- cites [17] Park WM et al (2002) Contemporary management of acute mesenteric ischemia: Factors associated with survival. J Vasc Surg 35(3):445–452 source
Not checked in the free run.
- Findingown data
Non-significant higher mortalities were observed in patients with multiple vessel occlusions (one vessel 43% vs. two vessels 42% vs. three vessels 50%; P=0.82).
“Also, non-significant higher mortalities were observed in patients with multiple vessel occlusions (one vessel 43% vs. two vessels 42% vs. three vessels 50%; P = 0.82).”
Quote in the paperNot a substantial claim - Findingown data
An increase in arteriosclerotic occlusions to the main etiology was observed in our study (49%).
“As with other authors in recent years, an increase in arteriosclerotic occlusions to the main etiology was also observed in our study (49%) [11, 17].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [11] Arthurs ZM et al (2011) A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53(3):698–705 source
Not checked in the free run.
- cites [17] Park WM et al (2002) Contemporary management of acute mesenteric ischemia: Factors associated with survival. J Vasc Surg 35(3):445–452 source
Not checked in the free run.
- Interpretationown data
Morbidity and mortality of acute mesenteric ischemia remains at a high level.
“Morbidity and mortality of AMI remains at a high level.”
Quote in the paperSubstantial claim - Interpretationown data
Conventional open or intraoperative endovascular therapy achieved similar results in patients with indication for laparotomy.
“Conventional open or intraoperative endovascular therapy achieved similar results in patients with indication for laparotomy.”
Quote in the paperSubstantial claim- Rests on an assumption: Restricting the comparison to patients who required laparotomy yields groups similar enough to compare open and endovascular treatment outcomes.
- Interpretationown data
A symptom-oriented diagnosis was impeded.
“Therefore, a symptom-oriented diagnosis was impeded.”
Quote in the paperSubstantial claim - Premisecitation
In older published studies, thromboembolic occlusions were the most common etiology with 35-45%.
“In older published studies, thromboembolic occlusions were the most common etiology with 35–45% [15, 16].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
A recent multicenter study showed that ROMS can be used in patients with AMI who do not respond to percutaneous endoluminal therapy due to mesenteric occlusion or are in need for laparotomy for exploration and treatment of ischemic bowel.
“A recent multicenter study showed that ROMS can be used in patients with AMI who do not respond to percutaneous endoluminal therapy due to mesenteric occlusion or are in need for laparotomy for exploration and treatment of ischemic bowel [24].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Oderich GS et al (2018) Multicenter study of retrograde open mesenteric artery stenting through laparotomy for treatment of acute and chronic mesenteric ischemia. J Vasc Surg 68(2):470–480.e1 source
Not checked in the free run.
- Study design and conductreasoning
Due to the retrospective study design, the time between symptom-onset and treatment begin could not be recorded reliably.
“Due to our retrospective study design, we were not able to record the time between symptom-onset and treatment begin reliably.”
Quote in the paperSubstantial claim - Interpretationown data
The high rate of postoperative acute renal failure (45%) is probably conditioned by the high prevalence of chronic renal insufficiency (35%) in our cohort.
“The high rate of postoperative acute renal failure (45%) is probably conditioned by the high prevalence of chronic renal insufficiency (35%) in our cohort.”
Quote in the paperNot a substantial claim - Interpretationcitation
The higher mortality of arteriosclerotic occlusions compared to embolic occlusions is probably due to a larger and more poorly compensated bowel ischemia.
“Moreover, arteriosclerotic occlusions were associated with higher mortality compared to embolic occlusions (53% vs. 34%; P = 0.11), probably due to a larger and more poorly compensated bowel ischemia [1, 11].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Berland T, Oldenburg WA (2008) Acute mesenteric ischemia. Curr Gastroenterol Rep 10(3):341–346 source
Not checked in the free run.
- cites [11] Arthurs ZM et al (2011) A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53(3):698–705 source
Not checked in the free run.
- Interpretationcitation
Our findings in perioperative course associated with mortality are consistent with other published studies despite the fact that only patients in clinically advanced stages with indication for laparotomy were included.
“Our findings in perioperative course associated with mortality are consistent with other published studies despite the fact that only patients in clinically advanced stages with indication for laparotomy were included [8–11, 14, 25, 26].”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [8] Hou L et al (2022) Outcomes of different acute mesenteric ischemia therapies in the last 20 years: A meta-analysis and systematic review. Vascular 30(4):669–680 source
Not checked in the free run.
- cites [9] Bala M et al (2022) Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. World J Emerg Surg 17(1):54 source
Not checked in the free run.
- cites [10] Ryer EJ et al (2012) Revascularization for acute mesenteric ischemia. J Vasc Surg 55(6):1682–1689 source
Not checked in the free run.
- cites [11] Arthurs ZM et al (2011) A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53(3):698–705 source
Not checked in the free run.
- cites [14] Schermerhorn ML et al (2009) Mesenteric Revascularization: Management and Outcomes in the United States 1988–2006. J Vasc Surg 50(2):341–348.e1 source
Not checked in the free run.
- cites [25] Beaulieu RJ et al (2014) Comparison of open and endovascular treatment of acute mesenteric ischemia. J Vasc Surg 59(1):159–164 source
Not checked in the free run.
- cites [26] Wu W, Liu J, Zhou Z (2020) Preoperative Risk Factors for Short-Term Postoperative Mortality of Acute Mesenteric Ischemia after Laparotomy: A Systematic Review and Meta-Analysis. Emerg Med Int 2020:1382475 source
Not checked in the free run.
- Interpretationown data
The major issue in the treatment of AMI is the delay in diagnosis and treatment due to unspecific abdominal symptoms.
“The major issue in the treatment of AMI is the delay in diagnosis and treatment due to unspecific abdominal symptoms.”
Quote in the paperSubstantial claim- Rests on an assumption: A wrong referral diagnosis is a valid proxy for delayed diagnosis and treatment of AMI.
- Premisecitation
To date, there are three surgical society guidelines with a tendency for an endovascular-first strategy.
“To date, there are three surgical society guidelines with a tendency for an endovascular-first strategy [2, 9, 12].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [2] Tilsed JV et al (2016) ESTES guidelines: acute mesenteric ischaemia. Eur J Trauma Emerg Surg 42(2):253–270 source
Not checked in the free run.
- cites [9] Bala M et al (2022) Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. World J Emerg Surg 17(1):54 source
Not checked in the free run.
- cites [12] Björck M et al (2017) Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 53(4):460–510 source
Not checked in the free run.
- Interpretationown data
The mortality of AMI remains at a high level.
“In conclusion, the mortality of AMI remains at a high level.”
Quote in the paperSubstantial claim - Interpretationnone given
Endovascular therapy can complement surgical revascularization for short central arteriosclerotic occlusions.
“Endovascular therapy can complement surgical revascularization for short central arteriosclerotic occlusions.”
Quote in the paperNot a substantial claim
- May combine two claims. 24
- Classified as probably not a substantial claim. 15
May combine two claims.
Findingown dataKaplan-Meier estimates for 1-year and 5-year survival were 85.5% and 58.8%.
“Kaplan-Meier estimates for 1-year and 5-year survival were 85.5% and 58.8% (Fig. 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe etiology of acute mesenteric ischemia was approximately 49% arteriosclerotic and 51% thromboembolic occlusions.
“The etiology of AMI was 49% arteriosclerotic and 51% thromboembolic occlusions.”
- Also stated in: § Clinical presentation and treatment of AMI · plain
“The etiology was acute atherosclerotic occlusion in 48.6% and thrombo-embolic in 51.4% of the patients.”
Quote in the paperNot a substantial claim- Also stated in: § Clinical presentation and treatment of AMI · plain
May combine two claims.
Findingown dataIn-hospital mortality was 41% in the open treatment group versus 53.8% in the endovascular treatment group, with P=0.54.
“The total in-hospital mortality manifested at 43% (n =32) (OT 41% vs. ET 53.8%; P=0.54).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe most common postoperative complications were acute kidney injury (44.6%), sepsis (56.8%), pulmonary complications (28.4%), and wound healing disorders (14.9%).
“The most common complications were acute kidney injury (44.6%), sepsis (56.8%), pulmonary complications (28.4%), and wound healing disorders (14.9%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSeventy-six patients were included in the study.
“Seventy-six patients (male n = 53, 71.6%; female n = 21, 28.4%) with a mean age of 73.6 ± 11.7 years were included.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingown dataThe clinical data of 74 patients treated for acute mesenteric ischemia from 2007 to 2021 were retrospectively reviewed and compared.
“The clinical data of 74 patients treated for AMI from 2007 to 2021 were retrospectively reviewed and compared.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn total, 61 patients (82%) were treated open surgically (OT) and 13 patients (18%) with an endovascular approach (ET) in combination with laparotomy.
“In total, 61 patients (82%) were treated open surgically (OT) and, 13 patients (18%) with an endovascular approach (ET) in combination with laparatomy.”
- Also stated in: § Study population and patient characteristics · plain
“The therapy of AMI was open treatment (OT) in 61 patients (82.4%) and endovascular treatment (ET) in 13 (17.6%).”
Quote in the paperNot a substantial claim- Also stated in: § Study population and patient characteristics · plain
May combine two claims.
Findingown dataIn our study, thromboembolic patients (51%) showed higher rates of atrial fibrillation (71%; P<0.01) and a more fulminant clinical symptomatology.
“In our study, these patients (51%) showed higher rates of atrial fibrillation (71%; P < 0.01) and a more fulminant clinical symptomatology.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPatients with pneumatosis intestinalis, remaining ischemic intestinal sections, acute kidney injury, septic multiorgan failure, and longer intensive care unit stays showed poorer survival.
“Further on, patients with pneumatosis intestinalis (71% vs. 29%; P = 0.01) as well as patients with remaining ischemic intestinal sections (60% vs. 40%; P = 0.02), postoperative complications such as acute kidney injury (61% vs. 39%; P < 0.01), septic multiorgan failure (92% vs. 8%; P < 0.01) and longer intensive care unit stays (P < 0.01) showed a poorer survival.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUnivariate analysis identified age, increased BMI, atrial fibrillation, increased lactate, and decreased blood pH values as negative predictors for survival.
“Univariate analysis identified age (77.1 ± 10.1 years vs. 71 ± 12.2 years; P = 0.03), increased BMI (27.5 ± 6.6kg/cm2 vs. 24.3 ± 6.1kg/cm2; P = 0.04), atrial fibrillation (69% vs. 31%; P = 0.03), increased lactate (P = 0.04) and decreased blood pH values (P = 0.03) as negative predictors for survival (Table 4).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOne patient required reintervention after three months due to kinking stenosis and another patient after 28 months due to re-stenosis in the anastomotic region.
“One patient required the reintervention after three months due to kinking stenosis and another patient after 28 months due to re-stenosis in the anastomotic region.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPatients with a thromboembolic nature of the occlusion tended to survive better (thromboembolic 59.5% vs. 40.6% and arteriosclerotic 40.5% vs. 59.4%), but at a non-significant level (P=0.11).
“Patients with a thromboembolic nature of the occlusion tended to survive better (thromboembolic 59.5% vs. 40.6% and arteriosclerotic 40.5% vs. 59.4%), but at a non-significant level (P = 0.11).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe cause of death was malignancy in three, myocardial infarction in two, and unknown in two patients.
“The cause of death was malignancy in three, myocardial infarction in two, and unknown in two patients.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCongestive heart failure or increased BMI had a negative influence on patient survival.
“Furthermore, we observe that congestive heart failure or increased BMI had a negative influence on patient survival.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOnly two further OT patients received endovascular stent implantation during follow-up into the inserted bypass.
“Only further two OT patients received endovascular stent implantation during follow-up into the inserted bypass.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFurther findings in preoperative diagnostic associated with mortality were pneumatosis intestinalis, increased lactate and LDH concentration as well as decreased blood pH-values.
“Further findings in preoperative diagnostic associated with mortality were pneumatosis intestinalis, increased lactate and LDH concentration as well as decreased blood pH-values (Tables 4 and 5).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMost patients presented with unspecific symptom complex of abdominal pain (100%), peritonism (31%), vomiting (26%) and diarrhea (16%), and 11% were already mechanically ventilated at presentation.
“Clinically, most patients presented with unspecific symptom complex of abdominal pain (100%), peritonism (31%), vomiting (26%) and diarrhea (16%), but also 11% of the patients were already mechanically ventilated at the time of presentation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFurther analysis of patients with unsuccessful endovascular interventions was performed as intention-to-treat (ITT).
“Further analysis of these patients was performed as intention-to-treat (ITT).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataAdvanced disease stage with ischemic intestinal sections at presentation and cardiovascular comorbidities were associated with adverse outcome.
“Advanced disease stage with ischemic intestinal sections at presentation and cardiovascular comorbidities were associated with adverse outcome.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningGiven the small number of patients treated with ET and the limited follow up, a comprehensive comparison was not believed appropriate, and selection bias cannot be avoided.
“Given the small number of patients treated with ET and the limited follow up, we did not believe that a comprehensive comparison would be appropriate, and also due to the fact that a selection bias cannot be avoided.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHou et al. reported conversion rates for endovascular treatment of 40-72%.
“As reported in a recent meta-analysis by Hou et al. conversion rates for endovascular treatment are 40-72% [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Hou L et al (2022) Outcomes of different acute mesenteric ischemia therapies in the last 20 years: A meta-analysis and systematic review. Vascular 30(4):669–680 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone givenThe heterogeneous study designs and lacking reporting standards for AMI lead to limited comparability of mortality in the treatment modalities.
“In conclusion, the heterogeneous study designs and lacking reporting standards for AMI lead to limited comparability of mortality in the treatment modalities.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationOnly arteriosclerotic occlusions were treated by ET, so the endovascular failure can be explained by the heavily calcified visceral aortas and mesenteric vessel orifices.
“In fact, only arteriosclerotic occlusions were treated by ET so that the endovascular failure can be explained by the heavily calcified visceral aortas and mesenteric vessel orifices [11, 23].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [11] Arthurs ZM et al (2011) A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53(3):698–705 source
Not checked in the free run.
- cites [23] Zacharias N et al (2016) Chronic mesenteric ischemia outcome analysis and predictors of endovascular failure. J Vasc Surg 63(6):1582–1587 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe existing laboratory diagnostic for AMI is only rarely specific and therefore only to be regarded as additive.
“Overall and as already confirmed in many studies, the existing laboratory diagnostic for AMI is only rarely specific and therefore only to be regarded as additive [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Acosta S, Nilsson T (2012) Current status on plasma biomarkers for acute mesenteric ischemia. J Thromb Thrombolysis 33(4):355–361 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Study design and conductnone givenDuring the long study period, progress in medical therapy and endovascular technology may have affected patients' outcomes.
“Furthermore, during the long study period, there has been a progress in medical therapy and endovascular technology that may have affected patients’ outcomes.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningWe focused our study exclusively on patients who received open or intraoperative endovascular surgery with subsequent laparotomy to limit the bias of the results.
“Therefore, we focused our study exclusively on patients who received open or intraoperative endovascular surgery with subsequent laparotomy to limit the bias of the results.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEckstein et al. mentioned the increased use of anticoagulants, the decreasing incidence of rheumatic valvular diseases, and the higher incidence of degenerative vascular diseases in the rising average age of the population as reasons for the increase in arteriosclerotic occlusions.
“As reasons for this Eckstein et al. mentioned the increased use of anticoagulants and the decreasing incidence of rheumatic valvular diseases as well as the higher incidence of degenerative vascular diseases in the rising average age of the population [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Eckstein HH (2003) Acute mesenteric ischemia. Resection or reconstruction? Chirurg 74(5):419–431 source
Not checked in the free run.
May combine two claims.
PremisecitationThe CTA was the imaging modality of choice in all cases and has proven to be highly sensitive and specific for the diagnosis of AMI.
“The CTA was the imaging modality of choice in all cases and has proven to be highly sensitive and specific for the diagnosis of AMI [4, 18].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Björck M et al (2017) Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 53(4):460–510 source
Not checked in the free run.
- cites [18] Aschoff AJ et al (2009) Evaluation of acute mesenteric ischemia: accuracy of biphasic mesenteric multi-detector CT angiography. Abdom Imaging 34(3):345–357 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAccording to Bala et al., the SMA is predestined for embolic events due to the large vessel diameter and sharp angulation.
“According to Bala et al. the SMA is predestined for embolic events due to the large vessel diameter and sharp angulation [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Bala M et al (2017) Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg 12(1):38 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSchermerhorn et al. found that mainly elderly patients with high comorbidities of cardiovascular diseases were affected by AMI and identified age and atrial fibrillation as predictors of poor survival.
“Consistent with our results, Schermerhorn et al. evaluated in the so far largest data analyses from the Nationwide Inpatient Sample (NIS), that mainly elderly patients with high comorbidities of cardiovascular diseases were affected by AMI and identified also age and atrial fibrillation as a predictor of poor survival [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Schermerhorn ML et al (2009) Mesenteric Revascularization: Management and Outcomes in the United States 1988–2006. J Vasc Surg 50(2):341–348.e1 source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningWe focused exclusively on surgically or endovascular treated patients with subsequent need for laparotomy and excluded purely endovascularly treated patients due to their better initial condition, which certainly worsens our mortality outcomes.
“As mentioned above, we focused exclusively on surgically or endovascular treated patients with subsequent need for laparotomy and excluded purely endovascularly treated patients due to their better initial condition, which certainly worsens our mortality outcomes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenIn our practical experience, most patients are already in critical condition at diagnosis or in a too advanced stage of disease for primary initial endovascular treatment as recommended.
“But in our practical experience, most patients are already in critical condition at diagnosis or in a too advanced stage of disease for primary initial endovascular treatment as recommended.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThese morphological constitutions represent a minority, so in actual practice open surgical revascularization plays a major role.
“However, these morphological constitutions represent a minority, so in actual practice open surgical revascularization plays a major role.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningThis study is a retrospective single center study, generating bias linked to a retrospective data collection.
“This study has some limitations. It is a retrospective single center study, generating bias linked to a retrospective data collection.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Most comparative series of endovascular versus open treatment for acute mesenteric ischemia are limited by small case numbers or short-term follow-up, so the quality of supporting data is restricted and the effect on outcomes remains unclear.
“Nevertheless, most comparative series are limited by small case numbers or short-term follow-up, so the quality of the supporting data is still restricted and the effect on the outcomes remains unclear.”
The paper relies on this without support.
Most patients with acute mesenteric ischemia are already in critical condition at diagnosis or in too advanced a stage of disease for primary initial endovascular treatment, leading to a discrepancy between theory and clinical practice.
“Additionally, most patients are already in critical condition at diagnosis or in a too advanced stage of disease for primary initial endovascular treatment, leading to a discrepancy between the theory in the literature and actual clinical practice.”
The paper relies on this without support.
Restricting the comparison to patients who required laparotomy yields groups similar enough to compare open and endovascular treatment outcomes.
“The purpose of this study was to review outcomes in AMI treatment with an open or endovascular approach in association with laparotomy and to evaluate the endovascular-first strategy in similar clinical situations.”
The paper relies on this without support.
A wrong referral diagnosis is a valid proxy for delayed diagnosis and treatment of AMI.
“Primary referral diagnosis of AMI was placed correctly in only 62% of the patients. Even so, patients with a wrong referral diagnosis had worse survival than patients with a correct referral diagnosis (38% vs. 63%; P= 0.07).”
“Due to our retrospective study design, we were not able to record the time between symptom-onset and treatment begin reliably.”
The paper relies on this without support.
The follow-up data available in 30/42 patients (65.3%) are representative of the entire cohort for the Kaplan-Meier survival estimates.
“The mean follow-up was 19 months (range 6.5–46 months) and available in 30/42 patients (65.3%).”
“Kaplan-Meier estimates for 1-year and 5-year survival were 85.5% and 58.8% (Fig. 3).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Comparative studies show similar outcomes between open and endovascular approaches in patients with indications for laparotomy.
“Comparative studies between open and endovascular approaches have shown similar outcomes in patients with indications for laparotomy [53,65].”
From Revascularization Strategies for Acute and Chronic Mesenteric Ischemia: A Narrative Review (2024) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Wrong-referral-diagnosis P-values differ
MajorThe text reports P = 0.07 for the survival comparison involving a wrong initial diagnosis, while Table 4 reports P = 0.54 for wrong referral diagnosis.
“Patients with an initial wrong clinical diagnosis tended to survive worse 37.5% (n =12) vs. 62.5% (n =20) (P = 0.07).”
“| wrong referral diagnosis | 15 (54) | 13 (46) | 0.54 |”
Additional bowel resection count differs between text and table
MajorThe postoperative-course text reports 22 patients requiring additional resection, whereas Table 3 reports 25.
“Furthermore, in the postoperative course 22 patients (29.7%) which have already undergone an initial resection, required additional resection from remaining ischemic intestinal sections.”
“| Additional resection** | 25 (34) |”
Intensive-care stay differs between text and table
MajorThe outcome text reports a median intensive-care stay of 11 days, range 5-26, while Table 3 reports 13 days, range 5-29.
“For the entire cohort, hospital stay was 23 days (range 14–37 days) and intensive care unit stay was 11 days (range 5–26 days).”
“| Intensive care unit stay, median (range) | 13 (5 - 29) |”
Short-range occlusion percentage does not match its count
MinorThe reported 26 short-range occlusions among 74 patients represent 35.1%, not 31.1%.
Reported 31.1 · recomputed 35.135135
“Long-range SMA occlusion was more frequent (64.9%, n = 51) than short-range (31.1%, n = 26).”
Count above Clavien-Dindo grade IIIa includes grade IIIa cases
MinorThe table lists 59 patients in grades IIIb through V, not 63. Its total reaches 63 only if the four grade IIIa patients are included, despite the text saying greater than grade IIIa.
Reported 63 · recomputed 59
“According to the Clavien-Dindo classification, 85.1% (n =63) patients developed complications greater than grade IIIa (Table 3) [13].”
Long-range SMA occlusion count differs between text and table
MinorThe text reports 51 long-range SMA occlusions, but Table 2 reports 48. The table's count also matches the stated 65% of 74 patients.
“Long-range SMA occlusion was more frequent (64.9%, n = 51) than short-range (31.1%, n = 26).”
“| Long-range (> 2cm) | 48 (65) |”
Chronic kidney disease prevalence differs in discussion
MinorThe discussion describes chronic renal insufficiency in 35% of the cohort, whereas the patient-characteristics section reports 29.7% and Table 1 reports 22 of 74 patients.
“The high rate of postoperative acute renal failure (45%) is probably conditioned by the high prevalence of chronic renal insufficiency (35%) in our cohort.”
“Other common comorbidities and risk factors were hypertension (87,8%), chronic kidney disease [GFR < 30ml/min/1.73m2] (29.7%), diabetes mellitus (43.2%) and congestive heart failure [NYHA II] (23%) (Table 1).”
Follow-up availability percentage is incorrect
MinorFollow-up available for 30 of 42 patients corresponds to 71.4%, not 65.3%.
Reported 65.3 · recomputed 71.428571
“The mean follow-up was 19 months (range 6.5–46 months) and available in 30/42 patients (65.3%).”
SMA-origin mortality percentage is incorrect
MinorTable 4 lists 21 deceased and 17 surviving patients with SMA-origin occlusion. The deceased share is therefore 21 of 38, or 55.3%, rather than the reported 44%.
Reported 44 · recomputed 55.263158
“| SMA origin occlusion | 21 (44) | 17 (59) | .05 |”
Initial bowel resection percentage does not match its count
MinorFifty-three of 74 patients represent 71.6%, not the reported 70.3%.
Reported 70.3 · recomputed 71.621622
“Initial bowel resection was necessary in 70.3% (n =53) of the cases.”
The stated cohort size does not match the sex counts
MinorThe reported 53 male and 21 female patients total 74, not 76. The treatment-group counts and tables also use 74 patients.
Reported 76 · recomputed 74
“Seventy-six patients (male n = 53, 71.6%; female n = 21, 28.4%) with a mean age of 73.6 ± 11.7 years were included.”
Acute kidney injury percentage in Table 3 is incorrect
MinorTable 3 reports acute kidney injury in 36 of 74 patients as 45%; that count represents 48.6%.
Reported 45 · recomputed 48.648649
“| Variable* | n = 74 (%) | | --- | --- | | Complications | | | Additional resection** | 25 (34) | | Wound healing disorder | 11 (15) | | Short-bowel syndrome | 8 (11) | | Aneurysm spurium | 2 (3) | | Acute kidney injury | 36 (45) |”
Hospital-stay range differs between text and table
MinorThe outcome text gives a hospital-stay range of 14-37 days, while Table 3 gives 11-42 days.
“For the entire cohort, hospital stay was 23 days (range 14–37 days) and intensive care unit stay was 11 days (range 5–26 days).”
“| Hospital length of stay, median (range) | 23 (11 - 42) |”
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378 · see citing works
Acute Mesenteric Ischemia: A Clinical Review
Oldenburg, W. A., Lau, L. L., Rodenberg, T. J., Edmonds, H. J., & Burger, C. D. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1054 · Cited by 714 · see citing works
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658 · see citing works
Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery
Bala, M., Kashuk, J., Moore, E. E., Kluger, Y., Biffl, W., Gomes, C. A., Ben-Ishay, O., Rubinstein, C., Balogh, Z. J., Civil, I., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0150-5 · Cited by 574 · see citing works
Contemporary management of acute mesenteric ischemia: Factors associated with survival
Park, W. M., Gloviczki, P., Cherry, K. J., Hallett, J. W., Bower, T. C., Panneton, J. M., Schleck, C., Ilstrup, D., Harmsen, W. S., & Noel, A. A. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.120373 · Cited by 463 · see citing works
ESTES guidelines: acute mesenteric ischaemia
Tilsed, J. V. T., Casamassima, A., Kurihara, H., Mariani, D., Martinez, I., Pereira, J., Ponchietti, L., Shamiyeh, A., al-Ayoubi, F., Barco, L. A. B., et al. (2016) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-016-0634-0 · Cited by 382 · see citing works
Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery.
Bala, M., Catena, F., Kashuk, J., De Simone, B., Gomes, C. A., Weber, D., Sartelli, M., Coccolini, F., Kluger, Y., Abu-Zidan, F. M., et al. (2022) · World Journal of Emergency Surgery · doi:10.1186/s13017-022-00443-x · Cited by 380 · cited 2× · see citing works
“To date, there are three surgical society guidelines with a tendency for an endovascular-first approach [2, 9, 12].”
BackgroundEpidemiology of Mesenteric Vascular Disease: Clinical Implications
Acosta, S. (2010) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2009.12.001 · Cited by 340 · see citing works
Mesenteric revascularization: management and outcomes in the United States, 1988-2006
Schermerhorn, M. L., Giles, K. A., Hamdan, A. D., Wyers, M. C., & Pomposelli, F. B. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.03.004 · Cited by 311 · see citing works
Arthurs, Z. M., Titus, J., Bannazadeh, M., Eagleton, M. J., Srivastava, S., Sarac, T. P., & Clair, D. G. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.09.049 · Cited by 285 · see citing works
Aschoff, A. J., Stuber, G., Becker, B. W., Hoffmann, M. H. K., Schmitz, B. L., Schelzig, H., & Jaeckle, T. (2009) · Abdominal Imaging · doi:10.1007/s00261-008-9392-8 · Cited by 223 · see citing works
Comparison of open and endovascular treatment of acute mesenteric ischemia
Beaulieu, R. J., Arnaoutakis, K. D., Abularrage, C. J., Efron, D. T., Schneider, E., & Black, J. H. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.06.084 · Cited by 222 · see citing works
Revascularization for acute mesenteric ischemia
Ryer, E. J., Kalra, M., Oderich, G. S., Duncan, A. A., Gloviczki, P., Cha, S., & Bower, T. C. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.12.017 · Cited by 188 · cited 1× · see citing works
“Since the establishment of endovascular procedures for the revascularization of visceral vessels in patients with chronic mesenteric ischemia, the endovascular approach is also increasingly preferred in AMI patients [10].”
BackgroundAcosta, S., Ögren, M., Sternby, N.-H., Bergqvist, D., & Björck, M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000154269.52294.57 · Cited by 162 · see citing works
Klar, E., Rahmanian, P. B., Bücker, A., Hauenstein, K., Jauch, K., & Luther, B. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0249 · Cited by 162 · see citing works
Current status on plasma biomarkers for acute mesenteric ischemia
Acosta, S., & Nilsson, T. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0660-z · Cited by 157 · see citing works
Acute Mesenteric Ischemia – A Clinical Review
Awais, D. S. A. D. M. (2018) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1489195 · Cited by 103 · see citing works
Oderich, G. S., Macedo, R., Stone, D. H., Woo, E. Y., Panneton, J. M., Resch, T., Dias, N. V., Sonesson, B., Schermerhorn, M. L., Lee, J. T., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.11.086 · Cited by 97 · see citing works
Serological markers for human intestinal ischemia: A systematic review
Derikx, J. P. M., Schellekens, D. H. S. M., & Acosta, S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.01.004 · Cited by 96 · see citing works
Berland, T., & Oldenburg, W. A. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0065-0 · Cited by 94 · see citing works
Die akute mesenteriale Ischämie: Resektion oder Rekonstruktion?
Eckstein, H.-H. (2003) · Der Chirurg · doi:10.1007/s00104-003-0630-x · Cited by 54 · see citing works
Chronic mesenteric ischemia outcome analysis and predictors of endovascular failure
Zacharias, N., Eghbalieh, S. D., Chang, B. B., Kreienberg, P. B., Roddy, S. P., Taggert, J. B., Sternbach, Y., & Darling, R. C. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2016.02.051 · Cited by 35 · see citing works
Hou, L., Wang, T., Wang, J., Zhao, J., & Yuan, D. (2022) · Vascular · doi:10.1177/17085381211024503 · Cited by 32 · see citing works
Wu, W., Liu, J., & Zhou, Z. (2020) · Emergency Medicine International · doi:10.1155/2020/1382475 · Cited by 20 · cited 1× · see citing works
“Our findings in perioperative course associated with mortality are consistent with other published studies despite the fact that only patients in clinically advanced stages with indication for laparotomy were included [8–11, 14, 25, 26].”
ResultLindstrom, D. J., Kettunen, H., Engström, J., & Lundberg, G. (2019) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2019.10.053 · Cited by 15 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Björck M et al (2017) Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 53(4):460–510 · DOI · Paper page
- Eckstein HH (2003) Acute mesenteric ischemia. Resection or reconstruction? Chirurg 74(5):419–431 · DOI · Paper page
Cited by
Sorted by citations
Shi, Y., Zhao, B., Zhou, Y., Chen, L., Su, H., & Gu, J. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.07.084 · Cited by 21 · see citing works
Revascularization Strategies for Acute and Chronic Mesenteric Ischemia: A Narrative Review
Gries, J. J., Sakamoto, T., Chen, B., Virk, H. U. H., Alam, M., & Krittanawong, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051217 · Cited by 19 · see citing works
Advancements in Revascularization Strategies for Acute Mesenteric Ischemia: A Comprehensive Review
Gries, J. J., Virk, H. U. H., Chen, B., Sakamoto, T., Alam, M., & Krittanawong, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020570 · Cited by 17 · see citing works
The pathophysiology of acute lung injury following intestinal ischemia-reperfusion
Palmier, M., Fraineau, S., Sutton, A., Hlawaty, H., Bellien, J., & Plissonnier, D. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00052.2025 · Cited by 10 · see citing works
Vrba, R., Řezáč, T., Špička, P., Klos, D., Černá, M., & Köcher, M. (2025) · Scientific Reports · doi:10.1038/s41598-024-84026-7 · Cited by 8 · see citing works
Zaman, M. N., Ali, W. H., Dost, W., Rasully, M. Q., Dost, R., Niazi, J., Dost, W., & Qasemi, F. (2025) · Cureus · doi:10.7759/cureus.85013 · Cited by 7 · see citing works
Current Approaches to Diagnosis and Management of Acute Mesenteric Ischaemia: A Scoping Review
Costello, L., Duggan, W. P., Flanagan, M. P., Toale, C., & Kavanagh, D. O. (2025) · Digestive Surgery · doi:10.1159/000547297 · Cited by 4 · see citing works
Qiu, Y., Zhang, Y.-H., Wu, Z., Yang, Z., Zhu, G., Miao, S., Chen, B., & Chen, F. (2024) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-024-02647-z · Cited by 4 · see citing works
Li, X., Lin, T., Chen, K., Wang, D., Yu, J., Wu, L., & Tang, L. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11481-6 · Cited by 1 · see citing works
Retrograde Open Mesenteric Stenting: A Case Report and Literature Review
Jeevaratnam, S., Farres, H., Polania-Sandoval, C. A., Claudio-Medina, Y., Morales-Arroyo, H., & Erben, Y. (2024) · Annals of Vascular Surgery - Brief Reports and Innovations · doi:10.1016/j.avsurg.2024.100319
Management of ischaemic bowel in the ICU patient
Blaser, A. R., Casian, D., & Lakbar, I. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001361
Mesenteric Ischemia and Risk Factors: Scoping Review with ☸SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/c40d2c54
Al-Amry, A. L., Obadiel, Y. A., Moghalles, G. M., Jowah, H. M., & Al-Mashramah, G. A. (2025) · Arab Board Medical Journal · doi:10.4103/abmj.abmj_4_25
- Authors
- Kapalla, M., Choubey, R., Weitz, J., Reeps, C., & Wolk, S.
- Affiliations
- University Hospital Carl Gustav Carus (DE)
- Corresponding author
- Kapalla, Marvin
- Venue
- Langenbeck's Archives of Surgery
- Published
- 2023-08-10
- Volume
- 408
- Issue
- 1
- Pages
- 303-303
- ISSN
- 0023-8236 (ISSN-L)
- 1435-2451
- PMC
- PMC10415437
- OpenAlex
- W4385716210
- Cited by
- 13
- References
- 25
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Langenbeck s Archives of Surgery (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, cc-by)
- Funders
- Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- Topics
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
- Health Sciences › Medicine › Surgery › Intestinal and Peritoneal Adhesions
- Keywords
- acute mesenteric ischemia, endovascular revascularization, open surgical revascularization, laparotomy, in-hospital mortality, mortality risk factors, pneumatosis intestinalis, lactate, thromboembolic occlusion, cardiovascular comorbidity
- MeSH terms
- Acute Disease, Humans, Ischemia, Laparotomy, Retrospective Studies, Risk Factors, Treatment Outcome, Endovascular Procedures, Mesenteric Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review